Toggle navigation
Home
People
Departments
Research
About
Login
Search
The TACtful Trial: A first-in-human multi-centre trial of BCMA specific T-cell antigen coupler infusion, generated from cryopreserved G-CSF-mobilized peripheral blood, in patients with relapsed and refractory multiple myeloma.
Grant
Overview
Affiliation
View All
Overview
date/time interval
October 1, 2023 - September 30, 2028
awarded by
Canadian Institutes of Health Research
total award amount
CAD 305618
Affiliation
contributor
Balitsky, Amaris Karin
Funded by
Bramson, Jonathan
Funded by
Mian, Hira
Funded by